Shurong Zhou
- Immunology top 10%
- Immunotherapy and Immune Responses 7
- interferon and immune responses 5
- Pharmaceutical Science top 10%
-
- RNA Interference and Gene Delivery 7
- Circular RNAs in diseases 2
- Advanced biosensing and bioanalysis techniques 2
- Glycosylation and Glycoproteins Research 1
-
- Cancer Immunotherapy and Biomarkers 5
-
- Cytomegalovirus and herpesvirus research 2
- Co-authors
- Guizhi ZhuLei MeiXiang LiuYu ZhangTing SuFurong ChengShuibin LinBing He
- Journals
- SHILAP Revista de lepidopterología (1 paper)Accounts of Chemical Research (1 paper)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesChinaNew Zealand
In The Last Decade
Shurong Zhou
16 papers receiving 664 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Immunology 235
- Cancer Research 152
- Pharmaceutical Science 56
- Biomaterials 88
- Molecular Biology 414
Countries citing papers authored by Shurong Zhou
This map shows the geographic impact of Shurong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shurong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shurong Zhou more than expected).
Fields of papers citing papers by Shurong Zhou
This network shows the impact of papers produced by Shurong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shurong Zhou. The network helps show where Shurong Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shurong Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | Small circular RNAs as vaccines for cancer immunotherapybreakdown → | 2025 | 23 |
| 4 | 2024 | 8 | |
| 5 | 2023 | 52 | |
| 6 | 2023 | 38 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 48 | |
| 9 | Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccinesbreakdown → | 2022 | 214 |
| 10 | 2022 | 65 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 36 | |
| 13 | 2020 | 30 | |
| 14 | 2020 | 25 | |
| 15 | 2019 | 45 | |
| 16 | 2018 | 34 | |
| 17 | 2018 | 45 |
About Shurong Zhou
Shurong Zhou is a scholar working on Immunology, Oncology and Molecular Biology, having authored 17 papers that have together received 673 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (7 papers), interferon and immune responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Circular RNAs in diseases (2 papers), Cytomegalovirus and herpesvirus research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (235 citations), Cancer Research (152 citations) and Pharmaceutical Science (56 citations). Shurong Zhou has collaborated with scholars based in United States, China and New Zealand. Frequent co-authors include Guizhi Zhu, Lei Mei, Xiang Liu, Yu Zhang, Ting Su, Furong Cheng, Shuibin Lin, Bing He, Xueqing Wang and Wenbing Dai. Their work appears in journals such as SHILAP Revista de lepidopterología, Accounts of Chemical Research and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.